Amgen Partners with Teijin in Pursuit of Bold Asia Plan
By Shannon Ellis
Wednesday, August 7, 2013
SHANGHAI Still avoiding discussion of its failed bid for Onyx Pharmaceuticals Inc. in June, Amgen Inc. continues to implement an ambitious Asia expansion strategy when it announced the launch of a new collaboration with Japan's Teijin Pharma Ltd. to search for new therapies for autoimmune diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.